{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T16:27:40Z","timestamp":1784651260855,"version":"3.55.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.japh.2016.05.004","type":"journal-article","created":{"date-parts":[[2016,9,3]],"date-time":"2016-09-03T02:59:35Z","timestamp":1472871575000},"page":"527-532.e1","source":"Crossref","is-referenced-by-count":37,"title":["Understanding community pharmacist perceptions and knowledge about HIV preexposure prophylaxis (PrEP) therapy in a Mountain West state"],"prefix":"10.1016","volume":"56","author":[{"given":"Elizabeth J.","family":"Unni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Kuykendall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/j.japh.2016.05.004_bib1","first-page":"657","article-title":"Prevalence of diagnosed and undiagnosed HIV infection\u2014United States, 2008-2012","volume":"64","author":"Hall","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.japh.2016.05.004_bib2","unstructured":"US Department of Health and Human Services. National HIV\/AIDS strategy for the United States. Available at: https:\/\/www.aids.gov\/federal-resources\/national-hiv-aids-strategy\/nhas-update.pdf. Accessed August 30,\u00a02015."},{"key":"10.1016\/j.japh.2016.05.004_bib3","unstructured":"Smith DK, Koenig LK, Martin M, et\u00a0al., US Public Health Service. Preexposure prophylaxis for the prevention of HIV infection in the United States. 2014. A clinical practice guideline from the Centers for Disease Control and Prevention. Available at: http:\/\/www.cdc.gov\/hiv\/pdf\/PrEPguidelines2014.pdf. Accessed August 30,\u00a02015."},{"key":"10.1016\/j.japh.2016.05.004_bib4","unstructured":"American Society of Health-System Pharmacists. ASHP guidelines on pharmacist involvement in HIV care. 2015. Available at: http:\/\/www.ashp.org\/DocLibrary\/BestPractices\/Guidelines-Pharmacist-Involvement-HIV-Care.aspx. Accessed February 13,\u00a02016."},{"key":"10.1016\/j.japh.2016.05.004_bib5","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/QAI.0000000000000780","article-title":"Understanding HIV care provider attitudes regarding intentions to prescribe PrEP","volume":"70","author":"Castel","year":"2015","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.japh.2016.05.004_bib6","unstructured":"Utah Department of Health. HIV infections, 2014. Available at: http:\/\/health.utah.gov\/epi\/diseases\/hivaids\/surveillance\/hiv_2014_infections_factsheet.pdf. Accessed February 13,\u00a02016."},{"key":"10.1016\/j.japh.2016.05.004_bib7","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1331\/JAPhA.2014.14014","article-title":"Exploratory survey of Florida pharmacists\u2019 experience, knowledge, and perception of HIV pre-exposure prophylaxis","volume":"54","author":"Shaeer","year":"2014","journal-title":"J\u00a0Am Pharm Assoc"},{"key":"10.1016\/j.japh.2016.05.004_bib8","series-title":"Mail and Internet Surveys: The Tailored Design Method","author":"Dillman","year":"2007"},{"key":"10.1016\/j.japh.2016.05.004_bib9","unstructured":"Centers for Disease Control and Prevention. PrEP. Available at: http:\/\/www.cdc.gov\/hiv\/pdf\/prep_fact_sheet_final.pdf. Accessed February 13,\u00a02016."},{"key":"10.1016\/j.japh.2016.05.004_bib10","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1748-5908-3-36","article-title":"Healthcare professionals\u2019 intentions and behaviors: a systematic review of studies based on social cognitive theories","volume":"3","author":"Godin","year":"2008","journal-title":"Implement Sci"},{"issue":"3","key":"10.1016\/j.japh.2016.05.004_bib11","doi-asserted-by":"crossref","first-page":"e91013","DOI":"10.1371\/journal.pone.0091013","article-title":"Development of a simple 12-item theory-based instrument to assess the impact of continuing professional development on clinical behavioral intentions","volume":"9","author":"Legare","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.japh.2016.05.004_bib12","series-title":"SPSS Statistics for Windows [computer program]. Version 21.0","author":"IBM","year":"2012"},{"issue":"2","key":"10.1016\/j.japh.2016.05.004_bib13","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4212\/cjhp.v65i2.1120","article-title":"Role of the pharmacist in caring for patients with HIV\/AIDS: clinical practice guidelines","volume":"65","author":"Tseng","year":"2012","journal-title":"Can J Hosp Pharm"},{"issue":"6","key":"10.1016\/j.japh.2016.05.004_bib14","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.farma.2010.07.001","article-title":"HIV clinical pharmacists\u2014the US perspective","volume":"34","author":"Scott","year":"2010","journal-title":"Farm Hosp"},{"key":"10.1016\/j.japh.2016.05.004_bib15","unstructured":"International Pharmaceutical Federation, World Health Organization. The role of the pharmacist in the fight against the HIV-AIDS pandemic. 1997. Available at: https:\/\/www.fip.org\/www\/uploads\/database_file.php?id=245. Acessed February 13,\u00a02016."},{"issue":"3","key":"10.1016\/j.japh.2016.05.004_bib16","doi-asserted-by":"crossref","first-page":"225","DOI":"10.4236\/pp.2014.53029","article-title":"The role of the pharmacist in pre-exposure prophylaxis","volume":"5","author":"Matyanga","year":"2014","journal-title":"Pharmacol Pharm"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319116306549?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319116306549?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T16:38:58Z","timestamp":1749573538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319116306549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S1544319116306549"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2016.05.004","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]}}}